A detailed history of Daiwa Securities Group Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 692 shares of BCRX stock, worth $5,307. This represents 0.0% of its overall portfolio holdings.

Number of Shares
692
Previous 692 -0.0%
Holding current value
$5,307
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$7.89 - $17.88 $1,317 - $2,985
167 Added 31.81%
692 $7,000
Q4 2021

Feb 03, 2022

SELL
$11.18 - $15.46 $983 - $1,360
-88 Reduced 14.36%
525 $7,000
Q3 2021

Nov 05, 2021

BUY
$14.21 - $17.65 $3,993 - $4,959
281 Added 84.64%
613 $9,000
Q4 2020

Feb 04, 2021

SELL
$3.37 - $8.61 $2,203 - $5,630
-654 Reduced 66.33%
332 $2,000
Q3 2020

Nov 02, 2020

BUY
$3.43 - $5.53 $401 - $647
117 Added 13.46%
986 $3,000
Q4 2019

Jan 31, 2020

BUY
$1.59 - $3.45 $273 - $593
172 Added 24.68%
869 $3,000
Q1 2019

Apr 26, 2019

BUY
$7.38 - $9.72 $1,129 - $1,487
153 Added 28.13%
697 $6,000
Q1 2018

May 02, 2018

BUY
$4.35 - $5.82 $2,366 - $3,166
544 New
544 $3,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.43B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.